The following pages link to Nivolumab
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Chemotherapy (links | edit)
- Lung cancer (links | edit)
- Myasthenia gravis (links | edit)
- Skin cancer (links | edit)
- Lymphoma (links | edit)
- Mesothelioma (links | edit)
- Monoclonal antibody (links | edit)
- Infliximab (links | edit)
- Renal cell carcinoma (links | edit)
- Kidney cancer (links | edit)
- Bristol Myers Squibb (links | edit)
- Sirolimus (links | edit)
- Everolimus (links | edit)
- Basiliximab (links | edit)
- Daclizumab (links | edit)
- Imatinib (links | edit)
- Trastuzumab (links | edit)
- Melanoma (links | edit)
- Head and neck cancer (links | edit)
- ATC code L (links | edit)
- ATC code L01 (links | edit)
- Gefitinib (links | edit)
- Small-cell carcinoma (links | edit)
- Rituximab (links | edit)
- Kaposi's sarcoma-associated herpesvirus (links | edit)
- Omalizumab (links | edit)
- Bevacizumab (links | edit)
- Cetuximab (links | edit)
- Cancer immunotherapy (links | edit)
- Adalimumab (links | edit)
- Natalizumab (links | edit)
- Erlotinib (links | edit)
- Merkel-cell carcinoma (links | edit)
- Ibritumomab tiuxetan (links | edit)
- Alemtuzumab (links | edit)
- Gemtuzumab ozogamicin (links | edit)
- Follicular lymphoma (links | edit)
- Targeted therapy (links | edit)
- Nodular melanoma (links | edit)
- List of human clusters of differentiation (links | edit)
- Sorafenib (links | edit)
- Sunitinib (links | edit)
- Theralizumab (links | edit)
- Humanized antibody (links | edit)
- Lapatinib (links | edit)
- Timeline of immunology (links | edit)
- Efalizumab (links | edit)
- Non-small-cell lung cancer (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)